{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:57:33Z","timestamp":1791615453505,"version":"4.3.4"},"reference-count":29,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Fungal systemic infections are a growing global health concern, particularly among immunocompromised individuals. Candida species are the leading cause of invasive fungal infections, with C. albicans historically being the most prevalent. The emergence of C. auris, known for its multidrug resistance, presents additional challenges for treatment and infection control. This study retrospectively analyzed minimal inhibitory concentration (MIC) data for common Candida species isolated from patients in the Galveston\u2013Houston Gulf Coast region from the EPIC Laboratory Information System (LIS) between October 2016 and September 2024. Antifungal susceptibility was assessed using the SensititreTM YeastOneTM YO9 AST Plate and interpreted per Clinical and Laboratory Standard Institute (CLSI) guidelines. A total of 1206 clinical yeast isolates from over 29 species were identified, with Candida species accounting for 94.5% (1140). C. albicans (30.7%), C. glabrata (23.5%), C. parapsilosis (12.2%), and C. tropicalis (10.4%) were the most prevalent. C. auris (6.2%) emerged in late 2021 in our region, showing high MICs against fluconazole (92%) and amphotericin B (32.2%). While C. albicans, C. parapsilosis, and C. tropicalis remained susceptible to echinocandins, fluconazole resistance showed an increasing trend. C. glabrata exhibited variable susceptibility to both echinocandins and azoles. These findings highlight the urgent need for enhanced antifungal stewardship, improved diagnostics, and novel therapeutic strategies. Continued regional surveillance and targeted interventions are essential to mitigating the impact of antifungal resistance.<\/jats:p>","DOI":"10.3390\/jof11030232","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T06:10:53Z","timestamp":1742364653000},"page":"232","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Trends in Antifungal Resistance Among Candida Species: An Eight-Year Retrospective Study in the Galveston\u2013Houston Gulf Coast Region"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1478-9252","authenticated-orcid":false,"given":"Michael D.","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4022-6667","authenticated-orcid":false,"given":"Ping","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3410\/M3-14","article-title":"Emerging fungal infections in immunocompromised patients","volume":"3","author":"Low","year":"2011","journal-title":"F1000 Med. Rep."},{"key":"ref_2","unstructured":"Mora Carpio, A.L., and Climaco, A. (2025). Candidemia. StatPearls, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4330\/wjc.v15.i10.469","article-title":"Candida endocarditis: Update on management considerations","volume":"15","author":"Jamil","year":"2023","journal-title":"World J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clinmicnews.2014.08.001","article-title":"Current epidemiology of candida infection","volume":"36","author":"Lockhart","year":"2014","journal-title":"Clin. Microbiol. Newsl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"615958","DOI":"10.1155\/2014\/615958","article-title":"Non-albicans Candida Infection: An Emerging Threat","volume":"2014","author":"Deorukhkar","year":"2014","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"ref_8","unstructured":"Sikora, A., Hashmi, M.F., and Zahra, F. (2025). Candida auris. StatPearls, StatPearls Publishing."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hayes, J.F. (2024). Candida auris: Epidemiology Update and a Review of Strategies to Prevent Spread. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226675"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mmy\/myy054","article-title":"Candida auris: The recent emergence of a multidrug-resistant fungal pathogen","volume":"57","author":"Forsberg","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3947\/ic.2022.0008","article-title":"Candida auris: An Overview of the Emerging Drug-Resistant Fungal Infection","volume":"54","author":"Sanyaolu","year":"2022","journal-title":"Infect. Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2020.01.037","article-title":"Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis","volume":"93","author":"Bienvenu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"dlab122","DOI":"10.1093\/jacamr\/dlab122","article-title":"Emergence of resistant Candida glabrata in Germany","volume":"3","author":"Aldejohann","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e0165221","DOI":"10.1128\/AAC.01652-21","article-title":"Impact of FKS1 Genotype on Echinocandin In Vitro Susceptibility in Candida auris and In Vivo Response in a Murine Model of Infection","volume":"66","author":"Sharma","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","unstructured":"CLSI (2024, August 07). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. CLSI Guideline M27-S4 2012., Available online: https:\/\/webstore.ansi.org\/standards\/clsi\/clsim27s4?srsltid=AfmBOorXfW5_ngh6gbIMm1__fmnJSAOy7uKEagcWIeaOXTgtuq4fvpfa."},{"key":"ref_17","unstructured":"CLSI (2024, August 07). Performance Standards for Antifungal Susceptibility Testing of Yeasts, 4th ed. CLSI Guideline M27. Available online: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m27\/."},{"key":"ref_18","unstructured":"CLSI (2024, August 07). Performance Standards for Antifungal Susceptibility Testing of Yeasts, 3rd ed. CLSI Guideline M27M44S. Available online: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m27m44s\/."},{"key":"ref_19","unstructured":"CLSI (2024, August 07). Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 4th ed. CLSI Guideline M57S. Available online: https:\/\/clsi.org\/media\/tbvf5qr2\/m57sed4e_sample.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-Based Active Surveillance for Culture-Confirmed Candidemia-Four Sites, United States, 2012-2016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill. Summ."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e0018123","DOI":"10.1128\/aac.00181-23","article-title":"Resistance to Fluconazole of Candida albicans in Vaginal Isolates: A 10-Year Study in a Clinical Referral Center","volume":"67","author":"Sobel","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e01001-20","DOI":"10.1128\/AAC.01001-20","article-title":"First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and\/or Y132F+K143R in Turkey","volume":"64","author":"Arastehfar","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Thomaz, D.Y., de Almeida, J.N., Sejas, O.N.E., Del Negro, G.M.B., Carvalho, G.O.M.H., Gimenes, V.M.F., de Souza, M.E.B., Arastehfar, A., Camargo, C.H., and Motta, A.L. (2021). Environmental Clonal Spread of Azole-Resistant Candida parapsilosis with Erg11-Y132F Mutation Causing a Large Candidemia Outbreak in a Brazilian Cancer Referral Center. J. Fungi, 7.","DOI":"10.3390\/jof7040259"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fan, X., Tsui, C.K.M., Chen, X., Wang, P., Liu, Z.-J., and Yang, C.-X. (2023). High prevalence of fluconazole resistant Candida tropicalis among candiduria samples in China: An ignored matter of concern. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1125241"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jgar.2021.03.018","article-title":"Trends towards lower azole susceptibility among 200 Candida tropicalis bloodstream isolates from Brazilian medical centres","volume":"25","author":"Favarello","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e0224221","DOI":"10.1128\/aac.02242-21","article-title":"Antifungal Resistance Trends of Candida auris Clinical Isolates in New York and New Jersey from 2016 to 2020","volume":"66","author":"Kilburn","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cerqueira, F.M., Bertsch, J., DeMaet, M.A., York, T., McDougal, A., Patel, J.A., and Ren, P. (2024). Enhancing Candida auris Surveillance in High-Risk Settings by Implementing a High-Throughput Molecular Assay on the Hologic Fusion Open Access Platform. J. Fungi, 10.","DOI":"10.3390\/jof10040285"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Calderaro, A., and Chezzi, C. (2024). MALDI-TOF MS: A Reliable Tool in the Real Life of the Clinical Microbiology Laboratory. Microorganisms, 12.","DOI":"10.3390\/microorganisms12020322"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Satam, H., Joshi, K., Mangrolia, U., Waghoo, S., Zaidi, G., Rawool, S., Thakare, R.P., Banday, S., Mishra, A.K., and Das, G. (2023). Next-Generation Sequencing Technology: Current Trends and Advancements. Biology, 12.","DOI":"10.3390\/biology12070997"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/3\/232\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:56:19Z","timestamp":1760028979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/3\/232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jof11030232"],"URL":"https:\/\/doi.org\/10.3390\/jof11030232","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}